Literature DB >> 1102902

Morphological and immunological characteristics of Streptococcus pyogenes, group A, type 50.

A Wildfeuer, B Heymer, W Schachenmayr, O Haferkamp.   

Abstract

Streptococcus pyogenes, group A, type 50, in contrast to other group A streptococci, causes spontaneous disease in mice thereby providing a suitable experimental model for the study of human streptococcosis. Type 50 possesses various peculiar morphological and immunobiological characteristics and under certain conditions forms and extremely thick non-antigenic capsule which seems to interfere with the binding of antibody. This interference is most likely responsible for the difficulties in detecting type 50 streptococci in the tissues of infected mice by immunofluorescent staining. Whereas the surface components (hyaluronic acid, M-antigen) of the type 50 Streptococcus exhibit several uncommon features, the more deeply located cell wall antigens, like peptidoglycan and C-carbohydrate, do not differ in either their chemical constituents or their serological reactions from the comparable components of other group A streptococci.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1102902     DOI: 10.1007/bf02121010

Source DB:  PubMed          Journal:  Med Microbiol Immunol        ISSN: 0300-8584            Impact factor:   3.402


  20 in total

1.  IMPROVED TECHNIQUE FOR THE PREPARATION OF STREPTOCOCCAL CELL WALLS.

Authors:  A S BLEIWEIS; W W KARAKAWA; R M KRAUSE
Journal:  J Bacteriol       Date:  1964-10       Impact factor: 3.490

2.  Identification of amino sugars.

Authors:  M J CRUMPTON
Journal:  Biochem J       Date:  1959-07       Impact factor: 3.857

3.  A specific color reaction of methylpentoses and a spectrophotometric micromethod for their determination.

Authors:  Z DISCHE; L B SHETTLES
Journal:  J Biol Chem       Date:  1948-09       Impact factor: 5.157

4.  Association of group A streptococci with an outbreak of cervical lymphadenitis in mice.

Authors:  J B NELSON
Journal:  Proc Soc Exp Biol Med       Date:  1954-07

Review 5.  Peptidoglycan types of bacterial cell walls and their taxonomic implications.

Authors:  K H Schleifer; O Kandler
Journal:  Bacteriol Rev       Date:  1972-12

6.  Streptococcal cell wall structure inducing hepatic granuloma.

Authors:  B Heymer; H Schäfer; W Schachenmayr; O Haferkamp; W C Schmidt
Journal:  Arch Pathol       Date:  1971-08

7.  Persisting streptococcal cell-wall components in murine chronic pyogenic nephritis.

Authors:  W Schachenmayr; B Heymer; O Haferkamp
Journal:  Virchows Arch A Pathol Pathol Anat       Date:  1972

Review 8.  Mechanisms of cell and tissue injury induced by group A streptococci: relation to poststreptococcal sequelae.

Authors:  I Ginsburg
Journal:  J Infect Dis       Date:  1972-09       Impact factor: 5.226

9.  A radioactive hapten-binding assay for measuring antibodies to the pentapeptide determinant of peptidoglycan.

Authors:  B Heymer; D Bernstein; K H Schleifer; R M Krause
Journal:  J Immunol       Date:  1975-04       Impact factor: 5.422

10.  THE ANTIGENIC COMPLEX OF STREPTOCOCCUS HAEMOLYTICUS : I. DEMONSTRATION OF A TYPE-SPECIFIC SUBSTANCE IN EXTRACTS OF STREPTOCOCCUS HAEMOLYTICUS.

Authors:  R C Lancefield
Journal:  J Exp Med       Date:  1928-01-01       Impact factor: 14.307

View more
  4 in total

1.  Recent advances in rheumatic fever control and future prospect: a WHO memorandum.

Authors: 
Journal:  Bull World Health Organ       Date:  1978       Impact factor: 9.408

2.  [Recent progress in the fight against acute arthritic rheumatism and future perspectives: WHO Memorandum].

Authors: 
Journal:  Bull World Health Organ       Date:  1979       Impact factor: 9.408

3.  DNA sequencing and gene expression of the emm gene cluster in an M50 group A streptococcus strain virulent for mice.

Authors:  D L Yung; S K Hollingshead
Journal:  Infect Immun       Date:  1996-06       Impact factor: 3.441

4.  The cervical lymph nodes in Streptococcus pyogenes, group A, type 50, infection in mice.

Authors:  A Wildfeuer; B Heymer; H Schäfer; O Haferkamp
Journal:  Med Microbiol Immunol       Date:  1978-07-04       Impact factor: 3.402

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.